This mission report outlines the HTA Capacity Building Workshop, held in Thimphu, Bhutan, from 6 to 8 October 2025. The workshop marked an important step in advancing the institutionalisation of Health Technology Assessment (HTA) within Bhutan’s health system. Jointly organised by the Health Interve

The Indonesian HTA Committee (InaHTAC) was formally renewed and continues its work as a facilitator of national HTA studies as of 2016. Under their oversight, three HTA economic evaluation studies were completed from 2014-2016: the economic evaluation of sildenafil as a first line treatment for pulm

The iDSI Indonesia project aims to institutionalize Health Technology Assessment in the country, to improve health system efficiency, and to prioritize interventions to ensure the longevity of the Universal Health Coverage Scheme or the Jaminan Kesehatan Nasional (JKN). In continuing support toward

The Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, has been working with the Health Technology Assessment Committee (HTAC), Ministry of Health, Indonesia, since 2014 under the auspices of the International Decision Support Initiative (iDSI). Si

The report summarises a visit to Tanzania and has been prepared by Mr. Panupong Chaowanasawat and Dr. Brandon Chua from the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. The study visit was supported by the Access and Delivery Partnership (ADP), led by the Unite

Abstract Surrogate endpoints are frequently used as primary outcomes in clinical trials. This is appropriate when they are validated for their ability to predict clinical benefit measured on patient-relevant target outcome(s). Such validation is often lacking, thus increasing uncertainty in the dec

Merck, the second-biggest U.S. drugmaker, on Wednesday said outside monitors recommended that its late-stage study of odanacatib, a new type of treatment, be stopped early because data has already shown it reduces fractures. Shares of Merck rose 4.2 percent on Thursday, on boosted hopes for the medi

Montarat Thavorncharoensap BSc, PhD*,** * Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand ** Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thaila